ACSL4 Expression Is Associated With CD8+ T Cell Infiltration and Immune Response in Bladder Cancer

por Wenjie Luo, Wenjie Luo, Jin Wang, Xiaoyan Dai, Xiaoyan Dai, Hailiang Zhang, Hailiang Zhang, Yuanyuan Qu, Yuanyuan Qu, Wenjun Xiao, Wenjun Xiao, Dingwei Ye, Dingwei Ye, Yiping Zhu, Yiping Zhu
Publicado 2021

Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients

por Weijie Gu, Junlong Wu, Xiaohang Liu, Hailiang Zhang, Guohai Shi, Yao Zhu, Dingwei Ye
Publicado 2017

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status

por Junlong Wu, Guowen Lin, Yao Zhu, Hailiang Zhang, Guohai Shi, Yijun Shen, Yiping Zhu, Bo Dai, Dingwei Ye
Publicado 2017

Integrating m6A Regulators-Mediated Methylation Modification Models and Tumor Immune Microenvironment Characterization in Caucasian and Chinese Low-Grade Gliomas

por Wangrui Liu, Wangrui Liu, Chuanyu Li, Yuhao Wu, Wenhao Xu, Shuxian Chen, Hailiang Zhang, Haineng Huang, Shuai Zhao, Jian Wang
Publicado 2021

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer

por Wenjie Luo, Jun Wang, Wenhao Xu, Chunguang Ma, Fangning Wan, Yongqiang Huang, Mengfei Yao, Hailiang Zhang, Yuanyuan Qu, Dingwei Ye, Yiping Zhu
Publicado 2021

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness

por Kun Chang, Yuanyuan Qu, Bo Dai, Jian-Yuan Zhao, Hualei Gan, Guohai Shi, Yiping Zhu, Yijun Shen, Yao Zhu, Hailiang Zhang, Dingwei Ye
Publicado 2017

Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis

por Xiaojian Qin, PhD, Dingwei Ye, PhD, Chengyuan Gu, PhD, Yongqiang Huang, PhD, Weijie Gu, PhD, Bo Dai, PhD, Hailiang Zhang, PhD, Yao Zhu, PhD, Han Yang, MS, Shuli Qu, MPH
Publicado 2021